Clinical Research Scientists

Current Studies

Vaccine

RSV (Respiratory Syncytial Virus) Vaccine

This study will measure the immune response to the vaccine.

View Trial Details

Ages:

18 - 49

Reimbursement:

up to $300

Trial Length:

Up to 28 days

Vaccine

RSV (Respiratory Syncytial Virus) Vaccine

This study is testing a new vaccine to protect women from getting sick from RSV.

View Trial Details

Ages:

18 - 49

Reimbursement:

up to $300

Trial Length:

Up to 6 months

Vaccine

RSV (Respiratory Syncytial Virus) Vaccine

This study will explore whether giving the study vaccine may help protect against RSV infection in people ages 60 and older.

View Trial Details

Ages:

60 +

Reimbursement:

up to $500

Trial Length:

Up to 3 years

Ages:

21 +

Reimbursement:

up to $600

Trial Length:

Up to 2 weeks